R87.62 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.

Use additional:
  • code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)

Type 1 excludes for R87.62 ICD 10 code
  • abnormal cytological findings in specimens from cervix uteri (R87.61-)
  • abnormal cytological findings in specimens from other female genital organs (R87.69)
  • carcinoma in situ of vagina (histologically confirmed) (D07.2)
  • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
  • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
  • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
  • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
  • severe dysplasia of vagina (histologically confirmed) (D07.2)

Type 2 excludes for R87.62 ICD 10 code
  • vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
  • vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)

Codes
Possible back-references that may be applicable or related to R87.62 ICD10 Code:

Present On Admission (POA Exempt)

R87.62 ICD 10 code is considered exempt from POA reporting